Allosteric Modalities for Membrane-Bound Receptors: Insights from Drug Hunting for Brain Diseases-Reference-Cited by-同舟云学术

Allosteric Modalities for Membrane-Bound Receptors: Insights from Drug Hunting for Brain Diseases

Published:2019-02-05 Issue:13 Volume:62 Page:5979-6002
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Coughlin Quinn,Hopper Allen T.,Blanco Maria-Jesus^ORCID,Tirunagaru Vijaya,Robichaud Albert J.,Doller Dario^ORCID

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b01651

Reference176 articles.

1. The daunting polygenicity of mental illness: making a new map

2. Rational Design of Small Molecules Targeting Oncogenic Noncoding RNAs from Sequence

3. Stott, K. Pharma’s broken business model—Part 2: Scraping the barrel in drug discovery. Endpoints News; Endpoints Company, May 2, 2018; https://endpts.com/pharmas-broken-business-model-part-2-scraping-the-barrel-in-drug-discovery/ Accessed on May 5, 2018.

4. Fragment screening to predict druggability (ligandability) and lead discovery success

5. New Modalities, Technologies, and Partnerships in Probe and Lead Generation: Enabling a Mode-of-Action Centric Paradigm

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies;Signal Transduction and Targeted Therapy;2024-08-23

2. Extrahelical Binding Site for a 1H-Imidazo[4,5-c]quinolin-4-amine A₃Adenosine Receptor Positive Allosteric Modulator on Helix 8 and Distal Portions of Transmembrane Domains 1 and 7;Molecular Pharmacology;2024-01-05

3. Characterization of allosteric modulators that disrupt androgen receptor co-activator protein-protein interactions to alter transactivation–Drug leads for metastatic castration resistant prostate cancer;SLAS Discovery;2023-10

4. Multitargeting nature of muscarinic orthosteric agonists and antagonists;Frontiers in Physiology;2022-09-06

5. Characterization of Dual-Acting A₃ Adenosine Receptor Positive Allosteric Modulators That Preferentially Enhance Adenosine-Induced Gα_i3 and Gα_oA Isoprotein Activation;ACS Pharmacology & Translational Science;2022-07-15